DEMUTH PETER (Chief Scientific Officer) exercised options at ELICIO THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 12/10/2025ACC: 0001601485-25-000130
Officer· Chief Scientific Officer
Since Feb 2026
0.00
Net shares
Net seller
$1.6K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
362.00 acquired · 362.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+362.00
Price / share
$4.41
Trade value
$1.60K
% of position
95.0%
12/9/2025
381.00→743.00
Total
Net shares
+362.00
Net value
$1.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/9/2025 | M · Option Exercise | +362.00 | $4.41 | $1.60K | 95.0% | 381.00 | 743.00 |
| Total | +362.00 | $1.60K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
362.00 shares
Shares
−362.00
Strike price
4.41
Held after
0.00
Exercisable
—
12/9/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock362.00 shares | 12/9/2025 | M · Option Exercise | −362.00 | 4.41 | — | 0.00 |